1. Tumor-infiltrating lymphocytes provides recent survival information for early-stage HER2-low-positive breast cancer: a large cohort retrospective study
   Teng Sun et al, 2023, Frontiers in Oncology CrossRef
2. Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy
   Cristina Arqueros et al, 2024, International Journal of Molecular Sciences CrossRef
3. Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence
   Shorouk Makhlouf et al, 2023, British Journal of Cancer CrossRef
4. Prognostic Relevance of Nuclear Receptors in Relation to Peritumoral Inflammation and Tumor Infiltration by Lymphocytes in Breast Cancer
   Melitta B. Köpke et al, 2022, Cancers CrossRef
5. Utility of human epidermal growth factor 2 heterogeneity as a prognostic factor in triple-negative breast cancer
   Eriko Narusawa et al, 2024, Medical Molecular Morphology CrossRef
6. One Step Nucleic Acid Amplification (OSNA) Lysate Samples Are Suitable to Establish a Transcriptional Metastatic Signature in Patients with Early Stage Hormone Receptors-Positive Breast Cancer
   Inês Gante et al, 2022, Cancers CrossRef
7. The Impact of Tumor Infiltrating Lymphocytes Densities and Ki67 Index on Residual Breast Cancer Burden following Neoadjuvant Chemotherapy
   Aya Elmahs et al, 2022, International Journal of Breast Cancer CrossRef
8. Canine melanoma: A review of diagnostics and comparative mechanisms of disease and immunotolerance in the era of the immunotherapies
   Valentina B. Stevenson et al, 2023, Frontiers in Veterinary Science CrossRef